The Alliance of Community Health Plans (ACHP) has submitted a comment letter about the U.S. Patent and Trademark’s Office (USPTO) initiatives to ensure the robustness and reliability of patent rights. In the letter, ACHP urges USPTO to consider several reforms to address the high cost of drugs.
New from ACHP:
- ACHP Letter to Office of Management and Budget Director Vought on Deregulation in Health Care
- Chronic Disease Pledge Bright Spot: Baylor Scott & White Health Plan’s Diabetes Management Program
- ACHP Statement on Energy & Commerce Committee Medicaid Markup
- ACHP Statement on “Most-Favored-Nation” Rx Pricing Executive Order
- ACHP Statement on Drug Pricing
- Ending the Allure of Drug Advertising
